Israel Englander Edwards Lifesciences Corp Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $1.28 Million - $1.43 Million	-15,200 Reduced 5.56%	258,300 $23.9 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $9.33 Million - $12.3 Million	-128,600 Reduced 31.98%	273,500 $26.1 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $7.43 Million - $9.36 Million	-120,400 Reduced 23.04%	402,100 $30.7 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $29.2 Million - $33.8 Million	358,800 Added 219.18%	522,500 $49.3 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $8.44 Million - $9.61 Million	113,700 Added 227.4%	163,700 $13.5 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $307,350 - $393,480	4,500 Added 9.89%	50,000 $3.73 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $2.81 Million - $3.66 Million	34,100 Added 299.12%	45,500 $3.76 Million

1,341

467M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.